BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20187063)

  • 1. Neoadjuvant therapy for pancreatic cancer: a current review.
    Abbott DE; Baker MS; Talamonti MS
    J Surg Oncol; 2010 Mar; 101(4):315-20. PubMed ID: 20187063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: current and future treatment strategies.
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
    Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
    J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatments for resectable pancreatic cancer.
    Ueno H; Kosuge T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative chemoradiation for pancreatic cancer.
    Evans DB
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S25-9. PubMed ID: 16399426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
    White RR; Tyler DS
    Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for adjuvant chemoradiation for pancreatic cancer.
    Garofalo M; Flannery T; Regine W
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):403-16. PubMed ID: 16549335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
    Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and controversies of adjuvant therapy for pancreatic cancer.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management of locally advanced pancreatic cancer.
    Maheshwari V; Moser AJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Aug; 2(8):356-64. PubMed ID: 16265403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for pancreatic cancer: current status, future directions.
    Regine WF; Abrams RA
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S10-3. PubMed ID: 17178279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.
    Evans DB; Erickson BA; Ritch P
    Ann Surg Oncol; 2010 Nov; 17(11):2803-5. PubMed ID: 20737218
    [No Abstract]   [Full Text] [Related]  

  • 18. New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.
    Berardi R; Verdecchia L; Scartozzi M; Cascinu S
    JOP; 2005 Jan; 6(1 Suppl):118-21. PubMed ID: 15650296
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant therapy for pancreatic cancer: a review.
    Zuckerman DS; Ryan DP
    Cancer; 2008 Jan; 112(2):243-9. PubMed ID: 18050292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.